Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prognostic relevance of tumor response after neoadjuvant therapy for patients with esophageal cancer.

Literature DB >> 31656807

Prognostic relevance of tumor response after neoadjuvant therapy for patients with esophageal cancer.

Elfriede Bollschweiler^1,2, Arnulf H Hölscher².

Abstract

Entities: Disease Species

Year: 2019 PMID： 31656807 PMCID： PMC6789346 DOI： 10.21037/atm.2019.08.36

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

19 in total

1. [Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation].

Authors: S E Baldus; S P Mönig; W Schröder; R Metzger; S Lang; T K Zirbes; J Thiele; R P Müller; H P Dienes; A H Hölscher; P M Schneider
Journal: Pathologe Date: 2004-11 Impact factor: 1.011

2. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment.

Authors: K Junker; M Thomas; K Schulmann; F Klinke; U Bosse; K M Müller
Journal: J Cancer Res Clin Oncol Date: 1997 Impact factor: 4.553

3. Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.

Authors: Eva Karamitopoulou; Svenja Thies; Inti Zlobec; Katja Ott; Marcus Feith; Julia Slotta-Huspenina; Florian Lordick; Karen Becker; Rupert Langer
Journal: Am J Surg Pathol Date: 2014-11 Impact factor: 6.394

4. Application of the 8th edition of the AJCC yTNM staging system shows improved prognostication in a single center cohort of esophageal carcinomas.

Authors: Dino Kröll; Laura Noser; Suna Erdem; Federico Storni; Dominik Arnold; Bastian Dislich; Inti Zlobec; Daniel Candinas; Christian A Seiler; Rupert Langer
Journal: Surg Oncol Date: 2018-01-31 Impact factor: 3.279

5. Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?

Authors: Katharina Puetz; Elfriede Bollschweiler; Robert Semrau; Stefan P Mönig; Arnulf H Hölscher; Uta Drebber
Journal: Histopathology Date: 2019-04 Impact factor: 5.087

6. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.

Authors: Paul M Schneider; Stephan E Baldus; Ralf Metzger; Martin Kocher; Rudolf Bongartz; Elfriede Bollschweiler; Hartmut Schaefer; Juergen Thiele; Hans P Dienes; Rolf P Mueller; Arnulf H Hoelscher
Journal: Ann Surg Date: 2005-11 Impact factor: 12.969

7. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Authors: T W Rice; H Ishwaran; W L Hofstetter; D P Kelsen; C Apperson-Hansen; E H Blackstone
Journal: Dis Esophagus Date: 2016-11 Impact factor: 3.429

8. Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma.

Authors: Arnulf H Hölscher; Uta Drebber; Henner Schmidt; Efriede Bollschweiler
Journal: Ann Surg Date: 2014-11 Impact factor: 12.969

9. Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard.

Authors: Claire L Donohoe; Naoimh J O'Farrell; Tim Grant; Sinead King; Lindsey Clarke; Cian Muldoon; John V Reynolds
Journal: Ann Surg Date: 2013-11 Impact factor: 12.969